A prospective open label add on treatment study of rufinamide in children with refractory epilepsy symptomatic of neuronal migration disorder
Latest Information Update: 04 Dec 2015
At a glance
- Drugs Rufinamide (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 04 Dec 2015 New trial record